Skip to main content

Sponsored By

ADC Therapy Treatment HER2+ and HER2-Low mBC

ADC Therapy Treatment HER2+ and HER2-Low mBC

Interview with the Innovators

Educating on HER2-Low mBC

Tajuana Bradley, MS, FNP-BC, Ryan Haumschild, PharmD, MS, MBA, Abbey J. Kaler, MS, APRN, FNP-C, Susie Ulloa, RN, OCN, ONN-CG

ADC Therapy Treatment HER2+ and HER2-Low mBC

Interview with the Innovators

Fostering Shared Treatment Decision-Making

Tajuana Bradley, MS, FNP-BC, Ryan Haumschild, PharmD, MS, MBA, Abbey J. Kaler, MS, APRN, FNP-C, Susie Ulloa, RN, OCN, ONN-CG

ADC Therapy Treatment HER2+ and HER2-Low mBC

Interview with the Innovators

Setting Appropriate Patient Goals of Therapy

Tajuana Bradley, MS, FNP-BC, Ryan Haumschild, PharmD, MS, MBA, Abbey J. Kaler, MS, APRN, FNP-C, Susie Ulloa, RN, OCN, ONN-CG

ADC Therapy Treatment HER2+ and HER2-Low mBC

Interview with the Innovators

Managing Patient Expectations and ADC-Related Side Effects

Tajuana Bradley, MS, FNP-BC, Ryan Haumschild, PharmD, MS, MBA, Abbey J. Kaler, MS, APRN, FNP-C, Susie Ulloa, RN, OCN, ONN-CG

ADC Therapy Treatment HER2+ and HER2-Low mBC

Interview with the Innovators

Care Team and Patient Resources and Tools for mBC

Tajuana Bradley, MS, FNP-BC, Ryan Haumschild, PharmD, MS, MBA, Abbey J. Kaler, MS, APRN, FNP-C, Susie Ulloa, RN, OCN, ONN-CG

ADC Therapy Treatment HER2+ and HER2-Low mBC

Interview with the Innovators

Assurance in ADC Therapy for HER2+ or HER2-Low mBC

Tajuana Bradley, MS, FNP-BC, Ryan Haumschild, PharmD, MS, MBA, Abbey J. Kaler, MS, APRN, FNP-C, Susie Ulloa, RN, OCN, ONN-CG

Results 1 - 6 of 6